RSS

MOHOY ECMOHO Limited

Last Post: 11/13/23
Followers: 0
Posts Today: 0
Views Today: 62

MOHOY Stock Quote & Tools

MOHOY Stock Message Board Discussion

Top 10 Most Recent News Articles

Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 44

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 0

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 207

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 165

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 343

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 275

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 14

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 210

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

STMicroelectronics Unveils Latest Financial Performance Insights

Updated Category News Views 215

Overview of STMicroelectronics’ Third Quarter Results STMicroelectronics N.V. (“ST”) (NYSE: STM), a prominent figure in the semiconductor sector, announced its financial results for the third quarter, showcasing a robust revenue of $3.25 billion. This figure represents a gross margin of 37.8% and an operating margin of 11.7%, culminating in a net income of $351...

Continue Reading
Celebrating the Unique Career Opportunities at McDonald's

Updated Category News Views 654

Explore the Benefits of Working at McDonald's Finding a meaningful job can be tough, but for many, McDonald's is more than just a fast-food place. It's a stepping stone for personal and professional development. Numerous individuals have experienced major career growth thanks to their time at McDonald's, reflecting the company’s dedication to helping its employees...

Continue Reading
Key Insights on New Fortress Energy Class Action & Legal Help

Updated Category News Views 153

Understanding the New Fortress Energy Class Action Investors in New Fortress Energy Inc. (NASDAQ: NFE) should be cognizant of legal developments surrounding their investments. This class action lawsuit emerges from concerns that misrepresentations regarding the company's revenue and growth forecasts misled investors during a designated class period. Important Details...

Continue Reading
Mauna Kea Technologies Reports Promising IBS Findings with Cellvizio

Updated Category News Views 58

Mauna Kea Technologies Presents Clinical Advances for Cellvizio in IBS Mauna Kea Technologies (Euronext Growth: ALMKT), the innovative creator of Cellvizio, recently unveiled new clinical insights regarding its advanced laser endomicroscopy system. This technology showcases potential in diagnosing and managing food intolerances, specifically focusing on individuals...

Continue Reading
Resilience in Asia's Stock Markets Amid Mixed Signals

Updated Category News Views 72

Resilience in Asia's Stock Markets Amid Mixed Signals Most Asian stocks showed little movement on a recent Friday, characterized by uncertainty regarding U.S. interest rates and the approaching presidential election. However, the situation was different for Chinese shares, which turned positive following data that revealed growth in the economy, meeting investor...

Continue Reading